FDA Inspection
Synthon Pharmaceuticals, IncSynthon Pharmaceuticals, Inc – FDA Inspection, Apr 3, 2009
Record Details
This FDA Inspection record concerns Synthon Pharmaceuticals, Inc, with an inspection on April 3, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Synthon Pharmaceuticals, Inc
- Inspection Date
- April 3, 2009
- Product Type
- Drugs
View Company Profile
ID · f5283d1b-96aa-443d-a84c-c362f817c0b5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 603514
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Synthon Pharmaceuticals, Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 18, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2010 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Synthon Pharmaceuticals, Inc
- FDA Inspection 782270 - 2012-05-18
- FDA Inspection 659289 - 2010-03-30
- FDA Inspection 658237 - 2010-03-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.